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Association studies are widely seen as the most promising approach for ﬁnding polymorphisms that inﬂuence
genetically complex traits, such as common diseases and responses to their treatment. Considerable interest has
therefore recently focused on the development of methods that efﬁciently screen genomic regions or whole genomes
for gene variants associated with complex phenotypes. One key element in this search is the use of linkage dis-
equilibrium to gain maximal information from typing a selected subset of highly informative single-nucleotide
polymorphism (SNP) markers, now often called “tagging SNPs” (tSNPs). Probably the most common approach to
linkage-disequilibrium gene mapping involves a three-step program: (1) characterization of the haplotype structure
in candidate genes or genomic regions of interest, (2) identiﬁcation of tSNPs sufﬁcient to represent the most common
haplotypes, and (3) typing of tSNPs in clinical material. Early deﬁnitions of tSNPs focused on the amount of
haplotype diversity that they explained. To select tSNPs that would have maximal power in a genetic association
study, however, we have developed optimization criteria based on the measure of association and have compared2r
these with other criteria based on the haplotype diversity. To evaluate the full program and to assess how well the
selected tags are likely to perform, we have determined the haplotype structure and have assessed tSNPs in the
SCN1A gene, an important candidate gene for sporadic epilepsy. We ﬁnd that as few as four tSNPs are predicted
to maintain a consistently high value with all other common SNPs in the gene, indicating that the tags could2r
be used in an association study with only a modest reduction in power relative to direct assays of all common
SNPs. This implies that very large case-control studies can be screened for variation in hundreds of candidate genes
with manageable experimental effort, once tSNPs are identiﬁed. However, our results also show that tSNPs identiﬁed
in one population may not necessarily perform well in another, indicating that the preliminary study to identify
tSNPs and the later case-control study should be performed in the same population. Our results also indicate that
tSNPs will not easily identify discrepant SNPs, which lie on importantly discriminating but apparently short ge-
nealogical branches. This could signiﬁcantly complicate tagging approaches for phenotypes inﬂuenced by variants
that have experienced positive selection.
Introduction
Recent developments have raised expectations that sta-
tistically powerful genetic association studies are now
feasible. These developments are as follows: increasing
knowledge of the human genome (e.g., from the Human
Genome Project), providing information about the loca-
tion and function of genes and allowing the systematic
evaluation of appropriate candidate genes for a given
disease or drug response; increasing availability of SNPs
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that can be used as markers within candidate regions;
and increasing knowledge about the biology of both
common diseases and the actions of drugs used in their
treatment. Finally—and most relevant to our purposes
here—there is the mounting evidence that the human
genome has much greater levels of linkage disequilib-
rium (LD) than previously predicted on the basis of the-
oretical models assuming an idealized demography and
uniform recombination (Kruglyak 1999). In some cases,
there are clear tracks, or “blocks,” of elevated LD in
which haplotype diversity is very limited (e.g., see Daly
et al. 2001; Goldstein 2001; Jeffreys et al. 2001). Taken
together, these developments lead us to suggest that the
most promising current approach to statistically pow-
erful genetic association studies (Goldstein 2001; John-
son et al. 2001) would be (a) to select either candidate
genes appropriate for the condition of interest or ge-
nomic regions that are implicated by linkage analyses;
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(b) to determine their haplotype structures in control
individuals from target populations for these genes or
regions; and (c) to select a (presumably small) number
of tagging SNPs (tSNPs) for analysis in clinical trials.
tSNPs (i.e., SNPs selected on the basis of their LD prop-
erties) have also been referred to as “haplotype tagging
SNPs” (htSNPs) (Johnson et al. 2001), but this belies
the fact that their immediate purpose in association stud-
ies is to tag other causal SNPs, not haplotypes per se
(Goldstein et al., in press).
Most of the details of how to implement such a pro-
gram remain to be determined, however, and a number
of concerns have been raised concerning its overall pros-
pects. For example, there are concerns about the quality
of the SNP databases, their applicability across popula-
tions, and such methodological issues as how to recog-
nize LD-block boundaries and deﬁne tSNPs within them.
More fundamental concerns have also been raised, such
as whether many of the gene variants that underlie com-
mon disease are themselves common, as postulated in the
common-disease/common-variant hypothesis (Chakravar-
ti 1999;Weiss and Clark 2002).Questions have also been
raised as to the extent to which LD in the human genome
is “blocklike,” the extent to which this requires or results
from heterogeneity in recombination rate along the ge-
nome, and the extent to which a simple haplotype struc-
ture within blocks requires or results from unusual demo-
graphic processes (e.g., a recent humanpopulationbottle-
neck) (Zhang et al. 2002). Simulations have also shown
that, even when recombination does occur mainly in
narrow hotspots, the pattern of LD may or may not be
functionally blocklike, depending on the demographic
history of the population (Stumpf and Goldstein 2003).
Although the idea of ﬁnding useful tSNPs does not in
itself depend on the existence or quality of LD blocks,
the pattern of LD will determine the properties of tags,
including the economy afforded by the use of tags and
the extent to which the tags will be carried across pop-
ulations. The detailed structure of recombination in the
human genome will affect these characteristics by its ef-
fect on LD patterns and on their similarities across pop-
ulations. Here, we are concerned with evaluating one
core aspect of this integrated program for genetic asso-
ciation studies: the resolution of haplotype structure and
the identiﬁcation and population-speciﬁcity of appropri-
ate tSNPs. For example, there are no agreed-upon pro-
tocols for the determination of haplotype structure nor
are there agreed-upon statistical approaches for the se-
lection and evaluation of tSNPs. It remains unclear how
much of an experimental savings may be afforded by the
use of tSNPs in the analysis of clinical material. Finally,
regardless of how tSNPs are identiﬁed, it is not clear how
well they can be transferred into new populations. Here,
we address these questions by determining the haplotype
structure of the SCN1A gene, a candidate gene in epi-
lepsy, and by evaluating the expected performance of
tSNPs in family samples of Chinese residents of Singa-
pore. These results were compared in a closely related
population (Malay residents of Singapore) and a more
distantly related population (Europeans).
The SCN1A Gene and Epilepsy
Neuronal hyperexcitability is a cardinal feature of the
pathophysiology of epilepsy. Sodium currents play an im-
portant role in the generation and propagation of the
action potential and, thus, in neuronal excitability, so
genes encoding the brain sodium channel (Nav1) are ma-
jor candidate genes for epilepsy. The sodium channel con-
sists of a principal pore-forming b subunit and two aux-
iliary b subunits (Catterall 2000). The a subunit exhibits
four homologous domains (I–IV), each of which has six
transmembrane segments (S1–S6). At least 11 different
genes, designated “SCN1A” through “SCN11A,” encode
the a subunit, and at least three different genes, desig-
nated “SCN1B” through “SCN3B,” encode the b sub-
unit (Plummer and Meisler 1999). Channels encoded by
SCN1A, SCN2A, SCN3A, SCN8A, and SCN5A are ex-
pressed in the human brain (Donahue et al. 2000; Whi-
taker et al. 2001). During recent years, mutations asso-
ciated with monogenic forms of human epilepsy have
been identiﬁed in SCN1A (Escayg et al. 2000, 2001;
Abou-Khalil et al. 2001; Claes et al. 2001; Sugawara et
al. 2001; Wallace et al. 2001), SCN2A (Sugawara et al.
2001), and SCN1B (Wallace et al. 1998).
The SCN1A gene is located on chromosome 2q24
and contains 27 exons, spanning ∼139 kb of genomic
sequence (Wallace et al. 2001). At least 24 different
mutations in various regions of the SCN1A gene have
been identiﬁed that cause Mendelian forms of epilepsy.
Of these, nine are associated with the clinical pheno-
type known as “generalized epilepsy with febrile sei-
zures plus” (GEFS [MIM 604233]) or variants in-
cluding partial seizures (Escayg et al. 2000, 2001;
Abou-Khalil et al. 2001; Sugawara et al. 2001; Wallace
et al. 2001). Expression studies of three of the GEFS
mutations in human cell lines showed defects in channel
inactivation, resulting in a persistent inward sodium
current during sustained depolarization (Lossin et al.
2002). This defect is likely to cause enhanced neuronal
excitability. These ﬁndings suggest that a gain of func-
tion is responsible for the increased seizure suscepti-
bility in these syndromes.
Fifteen other mutations in SCN1A have been identi-
ﬁed in patients with severe myoclonic epilepsy of infancy
(Claes et al. 2001; Sugawara 2002). These ﬁndings imply
that genetic variation at different sites in SCN1A contri-
butes to a wide range of seizure types. Therefore, SCN1A
is also considered to be a major candidate gene contribut-
ing to common, nonmonogenic epilepsies, which account
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for the majority of epilepsies. A recent study tested the
involvement of SCN1A variants in 165 familial and 61
sporadic cases of generalized idiopathic epilepsy and iden-
tiﬁed four possible disease-associated variants (Escayg et
al. 2001). The interest in this gene lies not only in its
possible causal role in epilepsy but also in its potential
inﬂuence on the efﬁcacy of antiepileptic drug treatment.
Many of the major antiepileptic drugs are known to act
by use-dependent and voltage-dependent inhibition of so-
dium currents by binding to critical amino acids located
in the S6 segment of domain IV of the sodium channel a
subunit (Kuo 1998; Catterall 1999). These ﬁndings sug-
gest that variations in SCN1A may also contribute to
antiepileptic-drug responsiveness. For these reasons, it is
timely to perform systematic screens for common poly-
morphisms in the sodium-channel genes that may (a) pre-
dispose to the common epilepsies and (b) inﬂuence the
response to the common antiepileptic drugs.
In a recent simulation study, Zhang et al. (2002) have
demonstrated that the tagging strategy can be efﬁcient
under a simple demographic model and the assumption
of uniform recombination. Although the generality of
recombination hotspots is unclear, it is now beyond dis-
pute that recombination rates in the human genome are
uneven. For a true appreciation of the economy afforded
by tags, this economy must therefore be empirically eval-
uated in the populations of interest. Here, we evaluate
the tagging approach empirically, by applying the mul-
tistep program to SCN1A, a candidate gene in which
there was little prior information concerning its pattern
of LD. One reason for our selection of SCN1A is that
it is a relatively large gene in terms of genomic sequence,
with many exons. For these reasons, it would be difﬁcult
to take a direct, resequencing approach to SCN1A in a
genetic association study. A panel of 24 SNPs and 1 in-
sertion/deletion polymorphism (indel) within SCN1A—
determined both from the public dbSNP database and,
de novo, from resequencing efforts—were investigated
within 32 Singapore Chinese trios, together with 6 SNPs
lying outside the SCN1A gene. The degree of popula-
tion-speciﬁcity of the tagging program was assessed by
typing a smaller panel of 15 markers (a subset of the
original 25) in 32 Singapore Malay trios and 32 trios
of European ancestry. Although LD patterns are known
to vary considerably from one region of the genome to
another, we chose the SNC1A gene without prior knowl-
edge of patterns of LD, thus ensuring that it was not
preselected for desirable LD properties.
Methods
Samples and SNP Detection
DNA was obtained from 32 trios (mother, father, and
child) of Chinese descent and 32 trios of Malay descent
from the population of Singapore (anonymized legacy col-
lection) and from 32 trios of European descent (CEPH
Utah collection). The Singapore Chinese trios were used
in the initial phase to ﬁnd a suitable initial panel of SNPs.
All exons known to harbor mutations in patients with
epilepsy at the time of our study were sequenced (Escayg
et al. 2000, 2001; Claes et al. 2001; Wallace et al. 2001),
because we were interested in ﬁnding any mutations, even
very rare ones, in these important exons. Primers to am-
plify these exonic sequences were taken from published
material (Claes et al. 2001; Wallace et al. 2001). Because
of their lower polymorphism levels, however, exonic se-
quencing is not the most efﬁcient method for ﬁnding
SNPs in order to describe haplotype structure. We there-
fore also performed resequencing in an additional 10
amplicons of an approximate length of 500 bp in introns
at various sites throughout SCN1A. Primers for these am-
plicons were designed using the Primer3 program, after
ﬁltering the genomic sequence (GenBank accession num-
ber AC010127) by use of the RepeatMasker program.
Where possible, the primers were designed around SNPs
present in the dbSNP database (i.e., where prior evidence
existed of polymorphism). In regions where no dbSNPs
were available, the amplicons were placed as far as pos-
sible between exonic amplicons, taking into account re-
petitive sequences.
PCR conditions were as follows: initial denaturation
at 95C for 15 min, followed by 35 cycles of denatur-
ation at 94C, annealing at 57C–63C, and extension
at 72C (each for 30 s), plus a ﬁnal extension phase of
10 min at 72C. PCR was performed with 5 ng of DNA,
2.5 mM of MgCl2, 0.2 mM of each dNTP, 0.5 mM of
each primer, and 0.25 U of Qiagen HotStartTaq poly-
merase, in a total volume of 10 ml. PCR products were
sequenced in both directions with a dideoxy terminator
kit and were analyzed with an automated sequencer (ABI
3100).
A total of 27 amplicons (17 exonic and 10 intron-
ic) were sequenced in all 32 Singapore Chinese trios.
Because initial results indicated that the entire gene
was composed of one block of LD, we subsequently
chose additional SNPs in short stretches ∼1.5 Mb,
∼170 kb, ∼100 kb, and ∼50 kb upstream and ∼140
kb, ∼190 kb, and ∼240 kb downstream of exon 1.
The following SNPs were chosen from the dbSNP data-
base: 1224648, 948473, 2155878, and 1919854 (up-
stream); and 1432272, 891819, and 2060167 (down-
stream). Primer design and PCR conditions were as
described above. First, each of these seven amplicons
was sequenced in 16–32 samples, to conﬁrm the pres-
ence of a polymorphic site, and, if a polymorphic site
was present, sequencing was performed in all 64 trios.
PCRs for the amplicon that contained dbSNP 1432272
failed, so this amplicon was removed from further con-
sideration.
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Error Checking
Of the 25 SNPs found within SCN1A, 6 were ran-
domly chosen for retyping within six randomly selected
Singapore Chinese trios, six Singapore Malay trios, and
four European trios. Among 264 successfully retyped
genotypes, eight discrepancies were found with the orig-
inal retypings, giving an estimated genotyping error rate
of 1.5% if it is assumed that new typings have the same
error rate as the original typings. A more conservative
estimate of 3.0% is obtained if it is assumed that the
new typings are without error (because extra care was
taken in producing these data). It is also possible to use
observed cases of Mendelian inconsistencies in the trio
data to estimate genotyping error. The new typings pro-
duced three cases of mother-father-child genotype sets
(from 75 full sets) that were inconsistent withMendelian
inheritance. Interestingly, in all three cases, the new typ-
ings matched the original typings, suggesting some bio-
chemical reason for consistent mistyping, given that pa-
rental status had been conﬁrmed at other loci. By as-
suming that the occurrence of more than one genotyping
error per mother-father-child genotype set is negligible
and that genotyping error affects only one allele in the
genotype (so homozygotes appear as heterozygotes and
heterozygotes appear as either homozygote with equal
probability), we calculated that only 28.0% of genotype
errors affecting mother-father-child genotype sets would
show up as a Mendelian inconsistency. The three ob-
served Mendelian inconsistencies therefore suggested a
genotyping error rate of 4.8%. However, since all cases
of Mendelian inconsistency in the original data set were
resolved either by retyping or by setting as missing data,
our calculation also suggested that the frequency of un-
detected genotyping error that remained in the original
data was 3.4%, consistent with the frequency of 3.0%
obtained with our earlier method based on retyping.
Taking 3.0% as our error rate, we note that, in individ-
uals genotyped for 25 loci (with two haplotypes per
individual), we would expect 31.5% of haplotypes to
be in error. We also note that, when we applied an expec-
tation-maximization (EM) algorithm to estimate haplo-
type frequencies from our 25-locus Singapore Chinese
data, 31.4% of the estimated gene pool was composed
of haplotypes with a frequency !2%, including many
apparently recombinant types (see the “Results” section
[“Haplotype Structure”]). It is therefore possible that all
these estimated low-frequency haplotypes are the result
of genotyping error. However, analysis presented later
indicates that, in spite of this possibility, the performance
of tagging-SNP sets quickly reached a plateau with in-
creasing set size, and that performance was thus affected
more by the properties of high LD and SNP redundancy
exhibited by the high-frequency haplotypes than by the
properties of low-frequency haplotypes.
Haplotype Structure
Despite the use of trios to help in the resolution of
phase, we found that only 36 of a possible 128 parental
chromosomes could be completely resolved into phased
haplotypes for all 25 markers within SCN1A, the failures
being due to either triple heterozygotes or missing data
at one or more locus. To make more efﬁcient use of the
data, we devised an EM estimation algorithm speciﬁcally
to deal with trio data. The algorithm combines infor-
mation from resolved and unresolved chromosomes and,
in unresolved cases, restricts the set of possible haplo-
types to those consistent with known data in both par-
ents and child. Full details will be presented elsewhere.
The algorithm is available in the TagIT software package
(see the Goldstein Lab Web site).
Selection of tSNPs—Performance Criteria
There is currently no consensus on the criterion that
best measures the performance of a set of tSNPs in the
capturing of information on haplotype structure within
a block. We analyzed and compared our data by using
a variety of different criteria, including all those used by
Johnson et al. (2001) and elaborated by Clayton (2002)
(criteria 4, 5, and 7–9 in table 1). Broadly, these criteria
can be split into two types: those based on capturing as
much as possible of the original haplotype diversity pres-
ent in the set of known SNPs K when reduced to the
smaller set H of tSNPs; and those based on establishing
as high an association as possible between the reduced
tSNP set H and the larger set K. The latter type is con-
cerned most directly with the issue of prediction—that
is, the ability of the reduced set H to detect unknown
SNPs in the set A of all SNPs within the block (where
H is a subset of K and K is a subset of A). In particular,
this framework allows a statistically natural approach
for assessing how well tSNPs are expected to perform
in a genetic association study, since one uses the set of
known SNPs K to make statistical statements about the
performance of the tSNPs H against the universe of all
SNPs A (see below).
Both diversity and association can be measured in dif-
ferent ways. Table 1 is by no means exhaustive but does
cover a number of sensible ways of deﬁning these terms.
The association-based criteria concentrate on , the co-2r
efﬁcient of determination (explained sum of squares di-
vided by total sum of squares) from ﬁtting a linear model
deﬁned in different ways, depending on the criterion in
question (but each based in some way on haplotype in-
formation provided by the tSNPs), to the allelic state
information at some locus i. Both diversity and associ-
ation can be expressed in ways that are mathematically
very similar. As an illustration of this, note that, in the
deﬁnition for the proportion of diversity explained in





1. tSNP groups G Number of haplotypes, or groups, deﬁned in the data set in question by the tSNP set
2. Haplotype-diversity ratio h /h[htSNP] Probability that two randomly chosen chromosomes are in different tSNP-deﬁned groups, given that they are in different
K-deﬁned haplotypes; is the tSNP-deﬁned haplotype diversity in the data set in question ( , where2h h p 1 f[htSNP] [htSNP] g
is the frequency of chromosomes in the gth tSNP-deﬁned group), and h is the haplotype diversity found using the setfg
K of all known SNPs in the data set
3. Minus largest confounded frequency max (f )con is the largest frequency of the second most common haplotype (deﬁned using the set K of all known SNPs)max (f )con
nested within any one tSNP-deﬁned group; all K-deﬁned haplotypes with frequency greater than will bemax (f )con
in separate tSNP-deﬁned groups
4. Proportion of diversity explained Pi Probability that two randomly chosen chromosomes are in different tSNP-deﬁned groups, given that they have different
allele types at locus i; ,where and (where n is the total number2 2P p 1 (R /D ) D p 2n f (1 f ) R p 2n  f (f  f )i i i i i i i gi g gi
of chromosomes in the data set [ does not depend on n, because the terms cancel], is the frequency of chromosomesP fi i
that have allele 1 at locus i (allele 1 may be arbitrarily assigned to either allele), and is the frequency of chromosomesfgi
both in the gth tSNP-deﬁned haplotype and that have allele 1 at locus i)
5. Minus residual diversity ¯R , where and (where T is the total number of pairwise comparisons within′ ′ 2 2 2¯Rp  (R /T) R p 2n  f (f  f )/f Tp n  fi i gi g gi g g
groups)
Association:
6. Haplotype 2r 2r[hap]i Coefﬁcient of determination from an analysis of variance of locus i among the G groups (coding alleles at locus i as “0” or
“1”); , where2 ′ ′ 2r p 1R /D R p 2n  f (f  f )/f[hap]i i i i gi g gi g
7. Best-single 2r 2r[sing]i Maximum of the G coefﬁcients of determination obtained by taking each tSNP-deﬁned haplotype in turn and performing an
analysis of variance of locus i among the two groups deﬁned by membership or nonmembership of the gth haplotype
8. Best-clumped 2r 2r[clump]i Maximum of the coefﬁcients of determination obtained by taking each way of clumping G tSNP-deﬁned haplotypes
G12  1
into two nonempty subsets and performing an analysis of variance of locus i among the two groups thus deﬁned
9. Chance-corrected haplotype 2r 2r[CChap]i Chance-corrected version of , to account for the amount of explained sum of squares that is expected by chance;
2r[hap]i
, where2 2 2r p (r  C)/(1 C) Cp n(1 f )/(n 1)[CChap]i [hap]i g
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Table 2
Summary Data on 31 Polymorphisms Typed in the Present Study
Marker Name






snp20 (rs1919854) Upstream O1 1,464 kb A/G 16.7 .788
snp21 (rs2155878) Upstream O2 168 kb A/G 3.2 .821
snp22 Upstream O2 168 kb G/A 2.9 .862
snp23 Upstream O2 168 kb G/A 3.1 .855
snp1 (rs590478) Intron 1 I1 49,740 A/G 34.4 .048
snp2 (rs573936) Intron 1 I1d 10,204 A/G 32.3 .154
snp3 Intron 1 I1d 10,203 C/T 15.3 .656
snp4 Intron 1 I1d 10,074 C/T 13.7 .211
snp4a (rs2892992) Intron 3 A1 11,706 A/T 37.7 .205
snp4b (rs1381108) Intron 3 A1 11,745 T/C 28.3 .248
snp4c (rs1381109) Intron 3 A1 11,854 A/C 40.6 .034
snp4d Intron 3 A1 11,982 T/C 39.1 .014
snp4e (rs1461199) Intron 3 A1 12,099 T/C 27.1 .764
snp4f (rs1461200) Intron 3 A1 12,122 A/G 32.0 .189
snp5 Intron 3 E2 15,135 T/C 28.1 .202
snp6 Intron 5 E5 20,590 T/G 12.5 .253
snp7 Intron 5 E5 20,605 A/G 40.6 .418
snp8 (rs2126152) Intron 14 E14 33,971 G/A 12.7 .986
snp9 Intron 14 E14 34,006 C/A 11.9 .283
snp9a Intron 14 A2 34,332 T/C 20.2 .682
snp9b (rs1019723) Intron 14 A2 34,388 C/T 33.1 .308
snp9c (rs1019724) Intron 14 A2 34,424 G/A 12.9 .243
snp9d (rs1019725) Intron 14 A2 34,439 C/T 26.7 .403
snp10 Intron 16 E16 37,068 T/C 12.5 .253
snp11g Exon 16 E16 37,361 A/G 12.5 .253
indel12 Intron 17 I17b 39,782–39,785 N/D 28.6 .186
snp13 Intron 17 I17b 39,877 G/A 10.5 .374
snp14 Intron 18 E18 59,651 T/C 14.3 .186
snp15 (rs919198) Intron 25 I25 78,969 G/A 13.3 .221
snp17 (rs891819) Downstream O3 187 kb G/A 30.3 .114
snp16 (rs2060167) Downstream O4 241 kb C/T 44.7 .160
a If present in the dbSNP database.
b As identiﬁed by Wallace et al. (2001).
c Position (in bp, unless otherwise indicated) according to June 2002 freeze of Human Genome Project
physical map, relative to ﬁrst base of exon 1 as identiﬁed by Wallace et al. (2001).
d With major allele given ﬁrst and minor allele given second.
e Using Singapore Chinese data, parents only.
f Test for Hardy-Weinberg equilibrium (Guo and Thompson 1992), using Singapore Chinese data,
parents only. No signiﬁcant P values were found, after Bonferroni correction.
g Reported previously as “exon 16: 3199 (T1067A)” by Escayg et al. (2001).
locus i in the data set in question and to the total sum
of squares in an analysis of variance of locus i among
the G groups (coding the alleles at locus i as “0” or
“1”). is proportional to a weighted-average residualRi
sum of squares in an analysis of variance among the G
groups (using weights for the residual sum of squaresfg
from each group, where is the frequency of the gthfg
group). If the unweighted (rather than the weighted)
residual diversity is used, , rather than , is obtained.2r P[hap]i i
Most criteria in table 1 result in a set of K values, one
for each of the K loci in the set of known SNPs K. This
raises the issue of how to reduce this set of K values to
a single number representing the performance of a tag-
ging set H. Two methods were used. The ﬁrst, “average-
locus” method takes a weighted average of all K values,
using weights , where is the frequency of thep (1 p ) pi i i
minor allele at locus i. This weighting is intuitively rea-
sonable in that loci with small values of (and lowpi
weight) have less information on haplotype structure.
For -based criteria, this weighting can also be moti-2r
vated as the overall coefﬁcient of determination from a
linear regression performed on the data from all loci com-
bined, comparing a model in which each locus can re-
spond differently to tSNP haplotype information with a
null model in which tSNP haplotype information does
not inﬂuence the allele frequency for each locus. This also
reﬂects the idea that low-frequency SNPs will be difﬁcult
to tag and thus are down-weighted in the selection cri-
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Figure 1 Structure of SCN1A and position of SNPs in and around the gene. Base-pair positions are relative to the ﬁrst base of SCN1A
exon 1. The bottom line represents ∼1.7 Mb of chromosome 2q24. The top line shows SCN1A enlarged, with exons represented by vertical
lines and boxes (ﬁrst exonp exon 1A; last exonp exon 26). Small horizontal lines show approximate location of amplicons (blackp published
primers; blue p newly designed primers). Arrows show the approximate positions of SNPs, with numbers above arrows if more than one
closely spaced SNP was detected (blue arrowsp dbSNPs polymorphic in our samples; green arrowsp dbSNPs not polymorphic in our samples;
red arrows p newly discovered SNPs). The red star indicates a 4-bp deletion in intron 17.
terion. The second, “worst-locus” method takes the min-
imum from the set of K values. The idea behind this
method is to ﬁnd sets of tSNPs that perform well even
for the worst case, as represented by the locus with the
lowest value for the criterion.
Results
SNPs Detected
Within SCN1A, 27 amplicons were sequenced (17 ex-
onic and 10 intronic). Of these, 11 contained one or more
polymorphic SNPs with a minor allele frequency10%.
Overall, 25 markers (1 exonic SNP, 23 intronic SNPs, and
1 intronic indel) were detected (table 2 and ﬁg. 1). Twelve
of these are dbSNPs (four dbSNPs included in our am-
plicons were not polymorphic in our samples), whereas
another SNP, located in exon 16, has been detected pre-
viously (Escayg et al. 2001). Thus, 12 of the 25 markers
detected within SCN1A are novel. All of these markers
are SNPs except for a novel triallelic polymorphism con-
sisting of a 4-bp indel with two forms for the inserted
sequence (an A/T polymorphism in the ﬁnal base). In-
formation on this marker is presented in table 2 as a bi-
allelic polymorphism (indel) only. For tagging purposes,
this marker was treated as binary so that all loci could
be treated equally, but we note that the A/T polymor-
phism in the ﬁnal base was found in very close associa-
tion with other loci, so little information was lost by
dropping it.
Of the six amplicons designed around SCN1A that suc-
cessfully ampliﬁed, four contained one or more polymor-
phic SNPs. The amplicons including dbSNPs 1919854,
2060167, and 898919 each contained one SNP as de-
scribed in the dbSNP database. The amplicon that in-
cluded dbSNP 2155878 contained the dbSNP plus two
additional, previously unidentiﬁed SNPs. Therefore, of
the six SNPs found outside SNC1A, two were novel.
Positional information and other summary data on all
these loci are presented in table 2 and ﬁgure 1. There is
no signiﬁcant evidence for a departure fromHardy-Wein-
berg equilibrium, after Bonferroni corrections are applied
to each locus.
Pattern of LD across SCN1A
LD was investigated between all pairs of loci by ﬁrst
estimating pairwise haplotype frequencies through use of
the trio-based EM algorithm, then assessing the statistical
strength of association via a likelihood-ratio test (compar-
ing EM frequencies with haplotype frequencies estimated
assuming no LD) and estimating the strength of associ-
ation through use of the LD measure. Restricting our′D
attention to the 25 SNPs located within the SCN1A gene,
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Table 3








A 0011101111010111110110111 21.6 20.5
B 1111110110111110011111111 14.2 15.9
C 1101011001111111111111111 10.8 15.9
D 1110011011111111111111100 10.8 13.6
E 1111011001111111111111111 9.2 18.2
F 1111110110100001001001011 5.7 6.8
G 0111110110100001001001011 2.5 4.5
H 1101110110111110011111111 1.7 2.3
I 1111110110100101001001011 1.7 2.3
J 1011101111010111110110111 1.7 …
K 0011110111010111110110111 1.7 …
a Haplotype designation.
b Loci are arranged in the order snp1–snp15 (as in table 2). A
haplotype is reported if observed in resolved chromosomes or if EM
frequency is 11%. 1 p major allele; 0 p minor allele.
c Frequencies estimated by the EM algorithm for trio data.
d Frequencies estimated from resolved parental chromosomes only.
spread over ∼130 kb, we found a signiﬁcant negative cor-
relation between and physical distance ( ,′D rp 0.299
and , using a two-tailed Mantel test with 105Pp .014
randomizations). However, signiﬁcant P values could be
found even between the most-widely-separated loci, indi-
cating that, although there was evidence for some recom-
bination (and/or gene conversion) throughout the gene,
the level of this recombination had not been enough to
break down the LD throughout the gene. When we ex-
amined LD with the SNPs lying outside the SCN1A gene,
we found signiﬁcant association of many SNPs (including
snp1) with snp17, but not with any other outside SNPs.
This suggests that a block of high LD extends at least as
far as 100 kb downstream of the end of SCN1A, but there
is no evidence that it extends as far as 160 kb downstream
or 120 kb upstream.
Haplotype Structure
The presence of signiﬁcant LD throughout the SCN1A
gene means that the smallest sufﬁcient tagging-SNP sets
will be found by consideration of haplotypes for the gene
as a whole. Table 3 presents estimated parental-gene-pool
haplotype frequencies for the entire SCN1A gene region
(25 SNPs), using data from the 32 Singapore Chinese
trios. The table compares estimates obtained using the
EM algorithm with those obtained using resolved paren-
tal chromosomes only. For individual haplotypes, the two
sets of estimates differ most notably in the frequency of
haplotype E (9.2% using EM vs. 18.2% using resolved
chromosomes). Another important difference between the
two sets of estimates is that 18.5% of the EM-estimated
gene pool is composed of 172 haplotypeswith frequencies
!1%, whereas, by deﬁnition, the minimum nonzero fre-
quency estimate in a sample of 44 resolved chromosomes
is 2.3%. Provided that chromosomes assort randomly and
that missing data are not dependent on the underlying
allele or genotype, the EM estimates should be more ac-
curate, because they are based on all the available infor-
mation. However, the fact that inferred haplotype fre-
quencies can be !1/128, even though a sample of 32 trios
has only 128 parental chromosomes, underlines that these
are only estimates of the true gene-pool frequencies,which
introduces an additional source of uncertainty when tSNP
performance is assessed.
Figure 2 shows a reduced median network for the
haplotypes in table 3 and illustrates several points in
regard to tagging-SNP efﬁciency. There is evidence
that long branches separate some of the major haplo-
types (A–D and F); these branches feature several
markers that are in complete LD because they fall on
the same branch, and this immediately suggests that
some level of tagging should be effective (to reduce
redundant typing on these branches). Conversely, one
discrepant SNP—that is, a single SNP that, on its own,
separates two high-frequency haplotypes—is also ev-
ident (see the “tSNPs—Assessment of Sufﬁciency”
subsection, below). In this case, snp3 is the only SNP
that separates haplotypes C and E. The ﬁgure also
reveals some evidence of recombination, gene con-
version, and/or typing error, in that some SNPs (spe-
ciﬁcally, snp1, snp3, snp4c, and snp7) appear in mul-
tiple places throughout the network; however, most
of these produce only minor haplotypes (e.g., G, H,
and K), with the exception of snp7, which separates
both A and F from other major haplotypes. Note,
however, that a small amount of recombination and/
or gene conversion may actually beneﬁt a tagging-SNP
strategy. This is because the same SNP may be used
to delineate more than one branch, whereas, under an
inﬁnite-sites no-recombination model, only one SNP
can ever delineate one branch.
tSNPs—Assessment of Sufﬁciency
The question of sufﬁciency can be broken into two
questions: (1) is the known SNP set K sufﬁciently large
to capture the haplotype structure in the full set A of
all possible SNPs? and (2) is the tSNP set H sufﬁcient
to capture the haplotype structure in K? There are some
issues common to both questions. One issue is that as-
ymptotic performance behavior (as one increases the size
of either H or K) provides an indication that it is not
worth increasing the size of either set. Another issue is
that it may be reasonable to assume that a causative SNP
x is drawn from the same distribution of SNPs as those
in K (but see below [“Sufﬁciency of K”]). In this case,
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Figure 2 Reduced median haplotype network based on data in
table 3. SNPs separating haplotypes are indicated on relevant branches.
Figure 3 Average performance of randomly chosen SNP sets of
sizeH. Performance indicators are as follows: solid circlesp haplotype
diversity ratio; squaresp weighted-average haplotype ; trianglesp2r
mean haplotype against excluded loci (maximum , because2r Hp 24
one locus is excluded); crosses p modal haplotype frequency; open
circles p largest confounded frequency.
dropping each SNP in turn from K and assessing the
power of the remaining SNPs to detect the excluded one
is a useful method to assess the sufﬁciency of H or K in
the detection of x. A ﬁnal issue is that the choice of the
performance criterion with which to assess sufﬁciency
must be considered. Because we are interested in the as-
sessment of performance in relation to a future test for
association with an unknown SNP, we choose to concen-
trate on association-based, rather than diversity-based,
measures of performance. Measures based on have2r
the advantage that they approximately represent the ef-
fective units of sample size in a case-control association
study (see Pritchard and Przeworski 2001 for the two-
allele case and Goldstein et al. 2003 for the case of more
than two alleles). We used haplotype as a general2r
measure because it can capture more types of association
than best-single or best-clumped measures (haplotype2r
can capture information on different levels of asso-2r
ciation in different haplotypes, whereas best-single 2r
and best-clumped reduce the problem to two groups2r
with the same level of association among haplotypes in
the same group, and their values can never exceed the
haplotype value). We used the weighted-average ver-2r
sion, rather than the worst-locus version, because the
former uses information from all loci. When we com-
pared best tSNP sets selected using the different weight-
ed-average performance criteria given in table 1, we
found that the weighted-average haplotype values2r
were at least 90% of the maximum possible value, pro-
vided that the number of SNPs in the set was greater
than three, indicating a high congruence among the dif-
ferent weighted-average performance criteria. In con-
trast, the worst-locus criteria exhibited much less con-
gruence, with worst-locus haplotype values being in2r
some cases only 3% of the maximum possible value for
tSNP sets of size three.
Sufﬁciency of K.—Figure 3 shows that the average
performance of randomly chosen SNP sets displays as-
ymptotic behavior as their size increases. If we can as-
sume that our set K is randomly chosen from all possible
sets of size , then we can extrapolate that meanK 1
performance will not be greatly altered by the addition
of one—or even several—SNPs. We can approximate the
ability of K to detect a causative SNP x by examining
the ability that tSNPs drawn from a reduced set of size
have to detect the SNP that has been excludedK 1
from the set (ﬁg. 4). Figure 4 reveals one SNP (snp3) for
which a low value (0.489) is obtained even when all2r
other SNPs are used to construct haplotypes. The reason
why snp3 is difﬁcult to tag is that it is the only SNP that
marks off a high-frequency haplotype (C) as distinct
from haplotype E. Most other high-frequency haplo-
types are distinguished from one another by multiple
SNPs. Haplotype C, however, is discrepant in having a
short branch length to the nearest other haplotype (as
measured by number of distinguishing SNPs) and, thus,
in appearing to be young yet occurring at a high fre-
quency. For this reason, we call the SNP that marks it
off (i.e., snp3) “discrepant.”
If discrepant SNPs, such as snp3, are included in the
set K, they will not cause a problem, as they will always
be selected as tags. But, if K were to be “exhaustively
sufﬁcient,” then we would want some assurance that
there are no such discrepant SNPs outsideK. This would
be achieved if no high-frequency haplotypes were de-
ﬁned by K, since undiscovered discrepant SNPs can oc-
cur only by breaking up an existing high-frequency hap-
lotype into two subcomponents. In principle, if enough
SNPs were sampled, then each individual chromosome
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Figure 4 Histogram of haplotype values between each of 252r
excluded loci and the remaining set of 24 SNPs. The lowest value is
for snp3.
Figure 5 Comparison of the performance of best tSNP sets
against the average performance of randomly chosen sets of size H.
Solid circles p weighted-average haplotype of best sets; open2r
circles p weighted-average haplotype of randomly chosen sets;2r
solid triangles p mean haplotype of best sets against excluded2r
loci (maximum , because one locus is excluded); open tri-Hp 24
angles p mean haplotype of randomly chosen sets against ex-2r
cluded loci.
would be unique, and no high-frequency haplotypes
would exist. In practice, the asymptotic behavior of the
curve describing the decrease in modal haplotype fre-
quency with SNP-set size (ﬁg. 3) suggests that K would
have to be very large to do this. A less exhaustively
sufﬁcient criterion for K would be to assess the proba-
bility that an unknown causative SNP, x, is a discrepant
SNP. Of the 25 sets of size , the probability thatK 1
is (i.e., when snp3 is excluded).2r ! 0.8 1/25p 0.04
The probability that x is a discrepant SNP and associates
poorly with K should therefore be no greater than 0.04.
This calculation, however, assumes that whether a SNP
is causal has no bearing on whether it is also discrepant.
But since causal SNPs have a phenotypic effect, this as-
sumption may not be justiﬁed. In fact, under some ver-
sions of the common-disease/common-variant hypoth-
esis, variants that cause predisposition to common dis-
ease may be positively selected in some populations or
in some genetic backgrounds. The variants then have their
deleterious effects only after a change in environment or
genetic background. Positive selection, however, can in-
crease the frequency of young haplotypes, leading to short
discriminating branch lengths for high-frequency haplo-
types and, therefore, to discrepant SNPs. To the extent
that positive selection has inﬂuenced the variants relevant
to disease predisposition and/or the genetics of variable
drug response, this could present a serious complication
to haplotype mapping by use of tSNPs.
Sufﬁciency of H.—Figure 5 conﬁrms that carefully se-
lected tSNP sets can outperform randomly selected sets
and can more quickly achieve performance levels close
to those available if all K SNPs were used. Indeed, it is
possible to reduce the tSNP-set size from 25 to 14 (56%
of the total) without any loss of performance at all, since
the 11 dropped SNPs all associate perfectly with SNPs
in the remaining 14. It is clear that there is no beneﬁt
to increasing the tSNP-set size beyond . FurtherHp 14
reductions in H are possible but would require a cost-
beneﬁt assessment weighing the cost of additional ge-
notyping against the beneﬁt of increased power to detect
a causative SNP x. The asymptotic behavior between
and H indicates a rule of diminishing returns. Figure2r
6 shows that, once , each additional SNP addedHp 6
to H only marginally increases power. Equivalent power
can be achieved by increasing the sample size by ∼1%
(using the approximate relationship that represents2r
the effective unit of sample size in a case-control asso-
ciation study [Pritchard and Przeworski 2001]). An op-
timal value for tSNP-set size H can be found if one is
willing to make a quantitative assessment of the cost of
additional genotyping against the cost of increasing sam-
ple size. In the most extreme case, sample collection in-
curs no cost; thus, the total cost is proportional to nH,
where n is the sample size, since this reﬂects the amount
of genotyping effort. In this case, the optimal size of H
is only 2 (ﬁg. 7). This allows us to place the optimal H
value between 2 and 14, with a reasonable value oc-
curring in the range 4–9.
tSNPs—Ability to Detect Low-Frequency SNPs
All the 25 SNPs in K have minor allele frequencies
110%. Thus, assessing the performance of tSNP sets
by use of K does not address the issue of how well
such sets are able to predict the state of low-frequency
SNPs. This issue is of concern because it not yet
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Figure 6 Percentage increase in mean haplotype of best sets2r
against excluded loci when H is increased to .H 1
Figure 7 Genotyping efﬁciency with increasing H. Efﬁciencyp
, where is the mean haplotype of best sets against excluded2 2 2r /H r r
loci (maximum , because one locus is excluded).Hp 24
known whether causative mutations are more likely
to be common or rare (Chakravarti 1999; Weiss and
Clark 2002). Our resequencing efforts in SCN1A un-
covered ﬁve low-frequency SNPs (with minor allele
frequencies of 0.82%, 0.86%, 0.94%, 1.69%, and
2.50%), in addition to the SNPs described so far. We
used these SNPs to assess best tSNP sets selected using
the Chinese data (ﬁg. 8). We found that the associa-
tion with these low-frequency SNPs was generally low,
although two SNPs displayed a sharp increase in 2r
as H increased to 10. In all cases, a plateau in with2r
increasing H was again observed. Thus, regardless of
how hard it would be to detect such low-frequency
SNPs, the chances of doing so are as good when using
a smaller set of tSNP loci as when typing all 25 high-
frequency loci, although a larger optimal H than for
higher-frequency SNPs is indicated.
tSNPs—Performance in Other Populations
A subset of 15 of the 25 SNPs in SCN1A were also
typed in 32 Singapore Malay trios (anonymized legacy
collection) and 32 trios of European ancestry (taken from
CEPH Utah pedigrees). Haplotype frequencies were es-
timated using the trio EM algorithm and were compared
with the Singapore Chinese trios (table 4). All three pop-
ulations were signiﬁcantly differentiated from each other
(exact test on known resolved chromosomes).Weassessed
the performance, in the other two populations, of the best
tSNP sets determined in the Singapore Chinese, using the
weighted-average haplotype criterion (ﬁgs. 9 and 10).2r
For the Malay data set, all tSNP sets performwithin 85%
of the possible maximum, and, for , the sets performH 1 4
within 95% of the maximum. For the European data set,
the tSNP sets perform very badly for , in some casesH ! 6
performing no better than a randomly chosen tSNP set.
For , however, performance is within 93.5% of theH  6
possible maximum.
Table 4 reveals the reason for this behavior. The
Singapore Malays and Singapore Chinese differ in es-
timated haplotype frequencies, but all the major hap-
lotypes (with frequency 15%) are found in both pop-
ulations. Thus, tSNP sets designed to distinguish hap-
lotype structure in the Singapore Chinese tend to do
well in the Singapore Malays also. In contrast, two
major haplotypes in the Singapore Chinese (haplo-
types 3 and 4) are completely absent in the European
sample, whereas other haplotypes important in the
Europeans (haplotypes 18 and 19) are completely ab-
sent in the Singapore Chinese. Furthermore, because
snp3 is an important discrepant SNP in the Singapore
Chinese, it appears in almost all best tSNP sets, yet
it is monomorphic in the Europeans so provides no
relevant information at all in this data set. These re-
sults show that tSNPs determined in one population
may not necessarily be good tSNPs in another if the
populations are sufﬁciently differentiated. This prob-
lem may be offset by increasing the size of the tSNP
set, but only at the cost of including possibly redun-
dant SNPs in the tSNP set. We also note that the set
K used to optimize the performance of the tSNP set
H was ascertained in the Singapore Chinese only and
that separate ascertainment of SNPs in the Singapore
Malays and Europeans could have led K to be differ-
ent in these populations and could further reduce the
performance of H.
Discussion
In the present study, we have veriﬁedmany of the elements
of the tagging approach to genetic association studies.
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Figure 8 Haplotype between each of ﬁve low-frequency2r
(!2.7%) loci and best tSNP sets of size H (chosen to maximize
weighted-average haplotype among 25 high-frequency SNPs).2r
Table 4
Haplotype Structure in Subset of SNPs in Singapore Chinese,








1 111111111111111 27.1 40.5 18.7
2 001101011110111 25.0 12.5 8.8
3 110111111111111 13.5 9.9 …
4 111011111111100 11.7 1.9 …
5 111110000001011 5.8 5.6 5.6
6 011110000001011 3.1 … .5
7 001111111111111 2.3 1.9 5.8
8 111110010001011 1.7 2.8 2.0
9 101101011110111 1.6 2.0 …
10 000101011110111 .8 … …
11 010111111111111 .8 6.6 …
12 111011111111111 .4 2.8 …
13 111001011110111 … 1.9 …
14 111111111111101 … 1.9 …
15 110111111101111 … 1.1 …
16 111111111110111 … 1.1 …
17 111101011110111 … 1.0 …
18 111111100111111 … … 15.0
19 111110011001011 … … 11.6
20 001110011001011 … … 4.4
21 101110011001011 … … 3.3
22 101110000001011 .9 … 2.3
23 001101000110111 … … 1.7
24 011011111111100 … … 1.6
25 011111111111111 … 1.0 1.4
26 001101010110111 … … 1.2
27 001110000001011 … … 1.1
28 111111110111111 … … .9
29 111111101111111 .8 … .9
30 001100011010111 … … .8
a Haplotype designation.
b Loci are arranged in the order snp1–snp15 (as in table 2), ex-
cluding snp4a–snp4f and snp9a–snp9d. Haplotypes are reported if
observed in resolved chromosomes or if EM frequency is 11% in at
least one population. 1 p major allele; 0 p minor allele.
Using only a modest amount of resequencing, we have
been able to determine the haplotype structure of a gen-
omically large candidate gene, SCN1A. Similar to earlier
reports (Daly et al. 2001; Johnson et al. 2001), we have
found a large block of LD within which haplotype di-
versity is low.
We did not characterize the location, width, or LD
properties of the boundaries of the high-LD block
that we found. However, since we established a min-
imum size for this block (290 kb, between snp1 and
snp16), many, if not all, functional mutations rele-
vant to SCN1A are likely to be within the same high-
LD region. We estimate that the set A of all SNPs in
this block is likely to contain 1500 SNPs with fre-
quency 110% (combining a genomewide nucleotide-
diversity estimate of [International4 p 7.51# 10
SNP Map Working Group 2001] with recent esti-
mates of SNP allele-frequency distributions [see the
Allele Frequency/Genotype Project Web site]). Our
ﬁnding of a large LD region, together with a simple
haplotype structure as deﬁned by our high-frequency
SNPs, indicated that a multistep approach to func-
tional-variant mapping could be effective for SCN1A.
We proceeded to test this through extensive analysis
of tSNP sets of various sizes.
Regardless of how tSNP sets were assessed, a plateau
in performance with increasing set size was observed.
The plateau is a reﬂection of redundancy in information,
with many loci displaying an “all-or-nothing” distribu-
tion of allelic state on haplotypic backgrounds deﬁned
by other loci. This redundancy means that, although an
optimal tSNP size depends on the criteria being used, it
is clear that the use of all 25 loci in a subsequent case-
control study would be pointless. Indeed, repeated testing
of individual loci for association would lead to greater
problems of multiple testing and reduced overall power
if all 25 loci were typed indiscriminately. Whereas other
methods account for the correlation structure of genea-
logical data (e.g., see Templeton et al. 2000), tSNPs pro-
vide the additional advantage of economy in terms of
time and cost.
Our analysis conﬁrmed that a small tSNP set could
be very effective in predicting the allelic state of an un-
known high-frequency causative mutation, given that
such mutations are likely to be part of the same haplo-
type structure as deﬁned by the 25 loci that we typed
within SCN1A. The savings relative to an exhaustive
search and assessment of all high-frequency loci within
the LD block are likely to be considerable. Using an
association-based criterion to select the best tSNP sets
(best-clumped , averaged over loci), we found that2r
only four tSNPs could predict the allelic state of an
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Figure 9 Weighted-average haplotype in the SingaporeMalay2r
data set for best tSNP sets of size H that were ascertained in the
Singapore Chinese data set (solid line)—compared with the average
performance of randomly chosen SNP sets (lower dotted line) and of
best tSNP sets ascertained using the Malay data set (upper dotted line).
Figure 10 Weighted-average haplotype in the European data2r
set for best tSNP sets of size H that were ascertained in the Singapore
Chinese data set (solid line)—compared with the average performance
of randomly chosen SNP sets (lower dotted line) and of best tSNP sets
ascertained using the European data set (upper dotted line).
excluded locus with an average coefﬁcient of determi-
nation of 0.89 in the Singapore Chinese data set. We
therefore estimate that we can match the power of typ-
ing all ∼500 high-frequency SNPs in the SCN1A LD
block by typing only four SNPs in a case-control study
with just a 13% increase in sample size for the Chinese.
This would represent a 110-fold savings in terms of
genotyping effort, and this is aside from the additional
effort of identifying all of these ∼500 SNPs in the be-
ginning. We also found that SNPs ascertained from the
public databases revealed the same haplotypic structure
as those found de novo from resequencing. This indi-
cates that further savings could be achieved by basing
the pilot set of known SNPs K on the public databases
only, provided that marker density is adequate and that
appropriate allowance for monomorphism in reported
SNPs is made (in the present study, 4 of 16 reported
dbSNPs were monomorphic).
Our results suggest that a case-control study to look
for functional variants in SCN1A could indeed yield
positive results, owing to the high association between
the haplotypes deﬁned by a small set of tSNPs and one
or more causal variants, but there are a number of
caveats. One of these is that, although the average
association with excluded loci is high, our data also
illustrate that there may be individual cases where as-
sociation is low. Discrepant SNPs that distinguish ap-
parently young haplotypes will not generally be well
tagged. Even in this worst-case scenario, however, the
discrepant snp3 has a coefﬁcient of determination of
0.54 in the Chinese data set, indicating that a 1.86-
fold increase in sample size would be needed to match
the power of a study that typed this SNP directly. Be-
cause snp3 is the only discrepant SNP in a set of 25,
it does not appear that this form of discrepancy will
present a serious obstacle to haplotype mapping by
use of tSNPs, unless causal SNPs are more likely to be
discrepant than average because of selection; if the
latter were the case, it could pose a serious compli-
cation, and this possibility requires further investiga-
tion. Interestingly, in this regard, snp3 not only is dis-
crepant but also has a sharp allele-frequency difference
between Europe (where no copies of the minor allele
were found) and Asia, consistent with the possibility
that it has been selected in recent times.
Another caveat is whether the causative SNP is at low
frequency. Our results suggest that a tSNP approach will
be less likely to be successful in identifying such loci. In
contrast, low-frequency causative SNPs will cause prob-
lems of low power even in exhaustive SNP-hunting asso-
ciation studies, especially if penetrance is low. Such loci
will be difﬁcult to identify, whatever method is used.
Unfortunately, the relative importance of rare and com-
mon SNPs in predisposition to common disease remains
poorly known (Pritchard 2001; Reich and Lander 2001).
For the case of variable drug response, however, the im-
portance of common variants is much better established
(Goldstein 2003).
A ﬁnal caveat is that our comparisons of the perfor-
mance of tSNP sets in populations other than the one
in which they were ascertained shows that tSNP sets
cannot always be ported from one population to an-
other. Instead, the results suggest that tSNP strategies
should be applied separately, at least within different
geographic areas. In contrast, the fact that tSNPs as-
certained in Singaporeans of Chinese ancestry can be
applied to Singaporeans of Malay ancestry provides
some reassurance that, within the major human an-
564 Am. J. Hum. Genet. 73:551–565, 2003
cestral geographic groups, tSNPs are portable among
populations. More work will be required in order to
verify this as a general rule, however.
A separate issue (aside from the ability of tSNPs to
detect a causative SNP) is how easy or difﬁcult it will
be to go on to pinpoint the location of the causative
SNP. In the most extreme scenario, LD across the entire
block could be so high that a causative SNP could lie
anywhere in the block on the associated chromosome.
In less extreme scenarios, rare recombination events
within the LD block could be used to indicate a more
local region for the causative SNP. Evidence for such
events can be found in our data, in which some low-
frequency haplotypes can be explained only by evoking
either recombination or recurrent mutation. It remains
to be seen, however, the extent to which low-frequency
recombinations can aid in localization of causative SNPs
within a block, especially in cases of incomplete pene-
trance, which weakens the association between pheno-
type and haplotypic background. In many cases, it seems
likely that functional assays will be required in order to
assess which of many putative causal variants are the
important ones.
For the purpose of the identiﬁcation of tSNP sets
that can predict allele states at unknown loci, criteria
that measure association are the most appropriate. The
best way to apply such criteria, however, is not obvi-
ous. This is hardly surprising, given that the best ways
to analyze multipoint genetic association studies—in-
corporating genotypic, rather than haplotypic, data—
remain issues open to debate. However, the criteria
that we have used are reasonable. Future analytical
developments may improve tSNP selection but will
leave the performance results presented here as ac-
ceptable minimums. As for the choice of optimal tSNP-
set size, this will depend on the relative importance of
individual sample size n versus genotyping effort n*H.
Although an exact solution would be possible only
through a formal decision-theoretic approach, solu-
tions for optimal tSNP-set size obtained under these
two extremes (n vs. n*H) provide upper and lower
limits to what the reasonable set size should be. For
our data, we show that, even using the upper limit for
tSNP-set size thus obtained, a very substantial savings
over the cost of genotyping all SNPs in the SCN1A
high-LD block would be obtained, with little or no
reduction in average power to detect high-frequency
causative SNPs.
Finally, we note that the tSNP-selection criterion that
we recommend, haplotype (implemented as criterion2r
5), relies on a linear model in which the haplotypes
formed by the tSNPs are independent predictors. If this
criterion is selected, then the performance expected on
the basis of the selection criterion will not necessarily
be realized, unless a linear model is used on the basis
of all the tSNP-deﬁned haplotypes observed in the cases
and the controls. It may not be sufﬁcient to individually
test either the tSNPs alone or the presence/absence of
single haplotypes that they deﬁne for frequency differ-
ences between cases and controls.
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